GW researchers successfully used CRISPR/Cas9 to limit the impact of schistosomiasis and liver fluke infection, affecting more than a quarter of a billion people in Southeast Asia, sub-Saharan Africa, and Latin America
For the first time, researchers at the George Washington University (GW), together with colleagues at institutes in Thailand, Australia, the U.K. and the Netherlands, and more, have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for schistosomiasis and for liver fluke infection, which can cause a diverse spectrum of human disease including bile duct cancer. Their findings are found in two papers published today in the journal eLife.
“The genes we ‘knocked out’ using CRISPR/Cas9 resulted in markedly diminished symptoms of infection in our animal models,” said Paul Brindley, PhD, professor of microbiology, immunology, and tropical medicine at the GW School of Medicine and Health Sciences, and lead author. “Our research also showed that this revolutionary new biomedical procedure — CRISPR/Cas9 — can be adapted to study helminth parasites, which are a major public health problem in tropical climates.”
CRISPR/Cas9 is a new technology that allows researchers to precisely target and deactivate the genetic information needed to produce a particular protein. While the tool has been used in other species before, it was unknown if it could be applied to Schistosoma mansoni and Opisthorchis viverrini, the parasites responsible for schistosomiasis and liver fluke infection.
Schistosomiasis can cause serious health problems, including damage to the liver and kidneys, infertility and bladder cancer. The freshwater worms S. mansoni enter the human body by burrowing into the skin; once in the bloodstream, they move to various organs where they rapidly start to reproduce. Their eggs release several molecules, including a protein known as omega-1 ribonuclease, which can damage the surrounding tissues. Brindley and his research team “knocked out” this protein using CRISPR/Cas9 and found that it greatly reduced the impact of the disease.
Liver fluke infection can cause a type of liver cancer called bile duct cancer, triggered by the presence of the worm O. viverrini. This parasite is transmitted through traditional Southeast Asian cuisines using uncooked or undercooked fish. Once inside the body, the parasite settles in the human liver and secretes a protein known as granulin that may encourage liver cells to multiply, raising the risk for cancer. Brindley and his research team used CRISPR/Cas9 to deactivate the gene that codes for granulin and create parasites that can only produce very little of the protein, leading to markedly reduced symptoms of liver fluke infection.
“These neglected tropical diseases affect more than a quarter of a billion people primarily living in Southeast Asia, sub-Saharan Africa, and Latin America,” said Brindley. “CRISPR/Cas9 is a tool that may be used to limit the impact of these infections. As we work to better understand how these parasites invade and damage our bodies through this new technology, we will find new ideas for treatment and disease control.”
The Latest on: CRISPR/Cas9
via Google News
The Latest on: CRISPR/Cas9
- Biotechnology could change the cattle industry. Will it succeed?on September 5, 2020 at 7:09 pm
Gene editing could help scientists produce cows that are meatier and better for the planet. But many hurdles remain ...
- Maximizing CRISPR/Cas9 phenotype penetrance applying predictive modeling of editing outcomes in Xenopus and zebrafish embryoson September 4, 2020 at 2:18 am
CRISPR/Cas9 genome editing has revolutionized functional genomics in vertebrates. However, CRISPR/Cas9 edited F 0 animals too often demonstrate variable phenotypic penetrance due ...
- Genome editing is NOT yet ready to be tried safely in humans and should only be used to treat serious single-gene diseases, scientists warnon September 3, 2020 at 8:00 am
Since the invention and development of Crispr-Cas9 around 15 years ago, a prevailing problem has been a lack of understanding of how safe the procedure is in the long-term. Researchers have ...
- Modulation of DNA double-strand break repair as a strategy to improve precise genome editingon September 3, 2020 at 7:28 am
In the present day, it is possible to incorporate targeted mutations or replace a gene using genome editing techniques such as customisable CRISPR/Cas9 system. Although induction of DNA double-strand ...
- New Method, IDMSeq, Quantifies CRISPR-Cas9 Editson September 3, 2020 at 5:00 am
A new approach, targeting individual DNA molecule sequencing (IDMseq), can accurately detect a single mutation in a pool of 10,000 cells.
- Should We Hack Our DNA?on September 2, 2020 at 7:46 am
Hack your DNA, and change your destiny. CRISPR-Cas9 is a gene editing tool that can eradicate diseases, and maybe one day even enhance our looks, personalities, and abilities. How does it do that ...
- Intellia Therapeutics to Present at Baird’s 2020 Virtual Global Healthcare Conferenceon September 2, 2020 at 5:41 am
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present at Baird’s 2 ...
- Israeli startup to use gene-editing tools to enhance cannabis seedson August 30, 2020 at 6:38 am
The Givat Chen, Israel-based firm, founded in 2017 by Ido Margalit and Tal Sherman, said it has received a nonexclusive intellectual property licensing agreement to use CRISPR-Cas9 gene editing ...
- Barcoding long DNA quantifies CRISPR effectson August 26, 2020 at 9:57 am
Current sequencing techniques lack the sensitivity to detect rare gene mutations in a pool of cells, which is particularly important, for example, in early cancer detection. Now, scientists at KAUST ...
via Bing News